Mercer Global Advisors Inc Bio Techne Corp Transaction History

Mercer Global Advisors Inc

$39.5 Billion
Q2 2024

A detailed history of Mercer Global Advisors Inc transactions in Bio Techne Corp stock. As of the latest transaction made, Mercer Global Advisors Inc holds 5,553 shares of TECH stock, worth $424,360. This represents 0.0% of its overall portfolio holdings.

Number of Shares

5,553

Previous 4,681 18.63%

Holding current value

$424,360

Previous $331,000 19.94%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$62.12 - $84.15 $54,168 - $73,378	872 Added 18.63%	5,553 $397,000
Q1 2024 May 15, 2024	BUY	$65.98 - $77.09 $30,482 - $35,615	462 Added 10.95%	4,681 $331,000
Q4 2023 Feb 14, 2024	SELL	$52.83 - $78.22 $17,116 - $25,343	-324 Reduced 7.13%	4,219 $326,000
Q3 2023 Nov 13, 2023	SELL	$67.52 - $89.42 $10,870 - $14,396	-161 Reduced 3.42%	4,543 $309,000
Q2 2023 Aug 14, 2023	SELL	$73.76 - $85.98 $156,592 - $182,535	-2,123 Reduced 31.1%	4,704 $383,000
Q1 2023 May 15, 2023	SELL	$71.62 - $86.62 $45,120 - $54,570	-630 Reduced 8.45%	6,827 $506,000
Q4 2022 Feb 08, 2023	BUY	$80.67 - $352.29 $405,366 - $1.77 Million	5,025 Added 206.62%	7,457 $618,000
Q3 2022 Nov 15, 2022	SELL	$282.54 - $391.85 $131,381 - $182,210	-465 Reduced 16.05%	2,432 $691,000
Q2 2022 Aug 10, 2022	SELL	$322.67 - $449.65 $331,382 - $461,790	-1,027 Reduced 26.17%	2,897 $1 Million
Q1 2022 May 10, 2022	BUY	$353.85 - $487.79 $90,231 - $124,386	255 Added 6.95%	3,924 $1.7 Million
Q4 2021 Feb 04, 2022	BUY	$456.15 - $525.06 $83,019 - $95,560	182 Added 5.22%	3,669 $1.9 Million
Q3 2021 Nov 10, 2021	SELL	$444.87 - $538.88 $62,726 - $75,982	-141 Reduced 3.89%	3,487 $1.69 Million
Q2 2021 Aug 10, 2021	BUY	$387.35 - $450.26 $18,980 - $22,062	49 Added 1.37%	3,628 $1.63 Million
Q1 2021 May 11, 2021	SELL	$314.62 - $411.0 $29,574 - $38,634	-94 Reduced 2.56%	3,579 $1.37 Million
Q4 2020 Feb 12, 2021	BUY	$246.9 - $321.87 $316,525 - $412,637	1,282 Added 53.62%	3,673 $1.17 Million
Q3 2020 Dec 10, 2020	BUY	$232.22 - $282.96 $15,558 - $18,958	67 Added 2.88%	2,391 $592,000
Q2 2020 Aug 10, 2020	SELL	$185.43 - $279.56 $30,225 - $45,568	-163 Reduced 6.55%	2,324 $614,000
Q1 2020 May 18, 2020	SELL	$161.17 - $221.51 $193,726 - $266,255	-1,202 Reduced 32.58%	2,487 $472,000
Q4 2019 Feb 13, 2020	SELL	$189.68 - $222.09 $151,933 - $177,894	-801 Reduced 17.84%	3,689 $810,000
Q3 2019 Nov 12, 2019	SELL	$183.56 - $216.72 $67,917 - $80,186	-370 Reduced 7.61%	4,490 $878,000
Q2 2019 Aug 14, 2019	SELL	$188.72 - $215.43 $14,531 - $16,588	-77 Reduced 1.56%	4,860 $1.01 Million
Q1 2019 Apr 23, 2019	BUY	$136.09 - $200.44 $671,876 - $989,572	4,937 New	4,937 $980,000

Others Institutions Holding TECH

# of Institutions

610

Shares Held

152M

Call Options Held

171K

Put Options Held

56.9K

View Full List

About BIO-TECHNE Corp

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $3B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

More about TECH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mercer Global Advisors Inc , based on Form 13F filings with the SEC.

News

Stay updated on Mercer Global Advisors Inc with notifications on news.

Account

Mercer Global Advisors Inc Bio Techne Corp Transaction History